Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NIH "Open Access" Plan Should Be Cooperative Venture With Publishers – NAS

This article was originally published in The Pink Sheet Daily

Executive Summary

The National Institutes of Health's proposal to make journal articles freely available six months after publication should maintain the credibility and authority of the peer review system, the Council of the National Academy of Sciences says.

You may also be interested in...



NIH/Publishers Meet On Open Access; Six-Month Schedule Is Key Concern

Publishers maintain free access to research six months after publication could destroy small scientific societies that publish their journals bimonthly or quarterly. Delegation raises concern that House language calling for open access violates the separation of congressional funding and authorization functions.

“Pharmaco-Metabonomics” Holds Promise for Personalized Drug Therapies, Researchers Say

The method uses a combination of advanced chemical analysis and mathematical modeling to predict drug response.

NCI-Funded Researchers Are Patenting At Surprisingly High Rate, Report Says

More than one in four National Cancer Institute-funded scientists start their own healthcare companies based on their own discoveries.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058118

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel